FindMyKOL
Clinical trialNCT01082224UnknownInterventional

Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

SponsorAmerican College of Radiology Imaging NetworkEnrollment440Liver Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Diagnostic procedures, such as contrast-enhanced CT scan and contrast-enhanced MRI, may help find liver cancer and find out how far the disease has spread. PURPOSE: This clinical trial is studying contrast-enhanced CT scan and contrast-enhanced MRI in diagnosing and staging liver cancer in patients with chronic liver disease.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uab Comprehensive Cancer Center

    Birmingham, Alabama, United States

  • Mayo Clinic Scottsdale

    Scottsdale, Arizona, United States

  • Usc/norris Comprehensive Cancer Center and Hospital

    Los Angeles, California, United States

  • Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • Lahey Clinic Medical Center - Burlington

    Burlington, Massachusetts, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

  • Washington University, St. Louis

    St Louis, Missouri, United States

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • the Methodist Hospital for Liver Disease and Transplant

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Iodinated contrast dyeMotexafin gadolinium →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2010
Primary completion
31 Dec 2023
Completion
31 Dec 2023
Last update posted
7 Jul 2023
Registered enrollment
440
Registry id
NCT01082224
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.